Clinical trials
Completed Phase 3 Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Eli Lilly and Company | 6 |
| Regeneron Pharmaceuticals | 4 |
| Amgen | 3 |
| Kastle Therapeutics, LLC | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Organon and Co | 2 |
| Ultragenyx Pharmaceutical Inc | 2 |
| 89bio, Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 36 |
| Diabetes Mellitus | 15 |
| Diabetes Mellitus, Type 2 | 15 |
| Glucose Metabolism Disorders | 15 |
| Endocrine System Diseases | 14 |
| Genetic Diseases, Inborn | 7 |
| Metabolism, Inborn Errors | 6 |
| Dyslipidemias | 5 |
| Hypercholesterolemia | 5 |
| Hyperlipidemias | 5 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.